Q4 2025 Earnings Call March 24, 2026 8:30 AM EDTCompany ParticipantsAndrew TsangJames Flynn - CEO & Chairman of ...

Woodward told The Associated Press during a recent interview that he saw the new book as a chance to “get into the reporting process in detail,” pointing out that he had hourslong conversations with ...

Management introduced a revised disclosure metric—portfolio LTM adjusted EBITDA—that combines adjusted EBITDA for KSX and ...

Good afternoon, and thank you for joining us for our fourth quarter 2025 earnings call and business update. Joining me today ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Welcome to Fennec Pharmaceuticals' Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. [Operator Instructions]. As a reminder, today's conference call is being recorded.

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Thank you for joining us today for Ecopetrol Group's Fourth Quarter and Full Year 2025 Results Call. Last year, we achieved ...

Marketing teams are at an inflection point. Generative AI, AI agents and intelligent assistants are fundamentally changing ...

Seed stage VC in 2026 rewards discipline over deal count. Black Operator Ventures partner Antonia Dean explains why ...

When Da’vonta Dashon “Squirrel” Robinson walked out of a Chesterfield County courtroom on Feb. 10, 2026, even he didn’t know ...